ArticleFrontiers in digital health2025
Challenges of identification and anonymity in time-continuous data from medical environments.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In medical environments, time-continuous data, such as electrocardiographic records, necessitates a distinct approach to anonymization due to the paramount importance of preserving its spatio-temporal integrity for optimal utility. A wide array of data types, characterized by their high sensitivity to the patient's well-being and their substantial interest to researchers, are generated. A significant proportion of this data may be of interest to researchers beyond the original purposes for which it was collected. This necessity underscores the pressing need for effective anonymization methods, a challenge that existing approaches often fail to adequately address. Robust privacy mechanisms are essential to uphold patient rights and ensure informed consent, particularly within the framework of the European Health Data Space. This paper explores the challenges and opportunities inherent in developing a novel approach to anonymize such data and devise suitable metrics to assess the efficacy of anonymization. One promising approach is the adoption of differential privacy to account for temporal context and correlations, making it suitable for time-continuous data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.